Literature DB >> 20084256

The place of quinolones in paediatric anti-infective therapy.

J Langley1.   

Abstract

Entities:  

Year:  2001        PMID： 20084256      PMCID： PMC2804755          DOI： 10.1093/pch/6.6.322

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  19 in total

1.  Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning.

Authors:  A Redmond; L Sweeney; M MacFarland; M Mitchell; S Daggett; R Kubin
Journal:  J Int Med Res       Date:  1998-12       Impact factor: 1.671

2.  A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group.

Authors:  X T Cao; R Kneen; T A Nguyen; D L Truong; N J White; C M Parry
Journal:  Pediatr Infect Dis J       Date:  1999-03       Impact factor: 2.129

Review 3.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

Review 4.  Quinolone arthropathy in animals versus children.

Authors:  J E Burkhardt; J N Walterspiel; U B Schaad
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

5.  Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review.

Authors:  V Krcméry; J Filka; J Uher; H Kurak; T Sagát; J Tuharský; I Novák; T Urbanová; K Kralinský; F Mateicka; T Krcméryová; L Jurga; M Sulcová; J Stencl; I Krúpová
Journal:  Diagn Microbiol Infect Dis       Date:  1999-09       Impact factor: 2.803

6.  Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.

Authors:  D A Church; J F Kanga; R J Kuhn; T T Rubio; W A Spohn; J C Stevens; B G Painter; B E Thurberg; D C Haverstock; R Y Perroncel; R M Echols
Journal:  Pediatr Infect Dis J       Date:  1997-01       Impact factor: 2.129

7.  Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated?

Authors:  J P Heggers; C Villarreal; P Edgar; S Wolf; G L Klein; S D John; M Desai; D N Herndon
Journal:  Arch Surg       Date:  1998-11

Review 8.  Fluoroquinolones in the treatment of cystic fibrosis.

Authors:  N Høiby; S S Pedersen; T Jensen; N H Valerius; C Koch
Journal:  Drugs       Date:  1993       Impact factor: 9.546

9.  Oral ciprofloxacin in the management of chronic suppurative otitis media without cholesteatoma in children: preliminary experience in 21 children.

Authors:  R Lang; S Goshen; A Raas-Rothschild; A Raz; D Ophir; B Wolach; I Berger
Journal:  Pediatr Infect Dis J       Date:  1992-11       Impact factor: 2.129

10.  Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin.

Authors:  J M Blondeau; M E Suter; S Borsos; C Misfeldt
Journal:  Int J Antimicrob Agents       Date:  1998-11       Impact factor: 5.283
View more
  1 in total

1.  Characterization of plasmid-mediated quinolone resistance (PMQR) genes in extended-spectrum β-lactamase-producing Enterobacteriaceae pediatric clinical isolates in Mexico.

Authors:  Jesus Silva-Sánchez; Enrique Cruz-Trujillo; Humberto Barrios; Fernando Reyna-Flores; Alejandro Sánchez-Pérez; Ulises Garza-Ramos
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.